Trial intelligence / Profile preview

Feasibility trial of sertraline, cognitive behavioural therapy, and their combination for obsessive compulsive disorder

2013-003219-22Phase 4Completed

Sponsor
Hertfordshire Partnership University NHS Foundation Trust
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of sertraline in obsessive compulsive disorder (OCD) (3 arms), sponsored by Hertfordshire Partnership University NHS Foundation Trust. Primary endpoints: Feasibility of conducting a larger randomized trial and Variation in Yale-Brown Obsessive Compulsive Scale score. Started Dec 2013; status: completed.

02

Drugs

sertraline
03

Conditions

obsessive compulsive disorder (OCD)

Beyond the preview

Go deeper on 2013-003219-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003219-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call